J&J Asks to Keep Risperdal Studies Under Seal

By
-
1
196

Law 360 reports that Johnson & Johnson asked a Pennsylvania judge to keep a series of clinical studies related to the drug Risperdal under seal, saying that the plaintiffs were improperly seeking to publicly release them.

Article →

Previous articleDSM-5 Boycott Enters 2nd Phase: A Primer for the NO-DSM Diagnosis Campaign
Next articleHow Can We Talk About Difficult Experiences Non-Violently?
Kermit Cole
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected].

1 COMMENT

LEAVE A REPLY